上海凯宝股价小幅下跌 实控人一致行动人减持992万股

Company Overview - Shanghai Kaibao's stock price is reported at 6.80 yuan, down 0.87% from the previous trading day, with a trading range of 6.77 to 6.93 yuan and a total transaction amount of 354 million yuan [1] - The company specializes in the research, production, and sales of traditional Chinese medicine, with key products including Tan Re Qing injection [1] Shareholder Activity - The controlling shareholder's concerted action partner, Xinxiang Kaiyi Trading Co., Ltd., reduced its stake in the company by 9.92 million shares between July 24 and July 30, accounting for 0.9485% of the total share capital [1] Financial Performance - In the first quarter of 2025, the company achieved an operating income of 401 million yuan and a net profit of 84.29 million yuan [1] Market Activity - On July 31, the main funds experienced a net outflow of 31.2036 million yuan [2]